- Home
- VANI vs MDCX Comparison
VANI vs MDCX Comparison
Compare VANI & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- MDCX
- Stock Information
- Founded
- VANI 1998
- MDCX 2008
- Country
- VANI United States
- MDCX Canada
- Employees
- VANI N/A
- MDCX N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- MDCX
- Sector
- VANI Health Care
- MDCX
- Exchange
- VANI Nasdaq
- MDCX Nasdaq
- Market Cap
- VANI 68.1M
- MDCX 44.0M
- IPO Year
- VANI 2014
- MDCX N/A
- Fundamental
- Price
- VANI $1.30
- MDCX $3.18
- Analyst Decision
- VANI Strong Buy
- MDCX Strong Buy
- Analyst Count
- VANI 1
- MDCX 2
- Target Price
- VANI $4.00
- MDCX $23.50
- AVG Volume (30 Days)
- VANI 156.1K
- MDCX 304.1K
- Earning Date
- VANI 08-12-2025
- MDCX 08-22-2025
- Dividend Yield
- VANI N/A
- MDCX N/A
- EPS Growth
- VANI N/A
- MDCX N/A
- EPS
- VANI N/A
- MDCX N/A
- Revenue
- VANI N/A
- MDCX N/A
- Revenue This Year
- VANI N/A
- MDCX N/A
- Revenue Next Year
- VANI N/A
- MDCX N/A
- P/E Ratio
- VANI N/A
- MDCX N/A
- Revenue Growth
- VANI N/A
- MDCX N/A
- 52 Week Low
- VANI $0.91
- MDCX $1.80
- 52 Week High
- VANI $1.50
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- VANI 71.88
- MDCX N/A
- Support Level
- VANI $1.13
- MDCX N/A
- Resistance Level
- VANI $1.33
- MDCX N/A
- Average True Range (ATR)
- VANI 0.07
- MDCX 0.00
- MACD
- VANI 0.01
- MDCX 0.00
- Stochastic Oscillator
- VANI 81.82
- MDCX 0.00
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.